• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Introduction to 2,6-Dimethoxy-3,5-pyridinediamine Hydrochloride (CAS No. 169381-75-3) and Its Emerging Applications in Chemical Biology

2,6-Dimethoxy-3,5-pyridinediamine Hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 169381-75-3, is a heterocyclic organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to the pyridine class of molecules, characterized by a six-membered aromatic ring containing two nitrogen atoms. The presence of methoxy groups at the 2- and 6-positions, along with diamine functional groups at the 3- and 5-positions, endows this molecule with unique chemical properties that make it a promising candidate for various biological and medicinal applications.

The hydrochloride salt form of 2,6-dimethoxy-3,5-pyridinediamine enhances its solubility in aqueous solutions, making it more suitable for in vitro and in vivo studies. This solubility advantage is critical for drug development, as it facilitates the formulation of pharmaceutical agents that can be effectively administered through different routes. The compound's structural features suggest potential interactions with biological targets such as enzymes and receptors, which are pivotal in modulating cellular processes.

Recent research has highlighted the significance of pyridine derivatives in medicinal chemistry due to their ability to mimic natural biomolecules and interfere with disease pathways. Specifically, the diamine moiety in 2,6-dimethoxy-3,5-pyridinediamine Hydrochloride can serve as a scaffold for designing small-molecule inhibitors targeting various therapeutic areas. For instance, studies have demonstrated its potential in inhibiting enzymes involved in cancer metabolism and inflammation.

In the realm of oncology, the development of novel chemotherapeutic agents is a continuous pursuit. The structural motif of 2,6-dimethoxy-3,5-pyridinediamine Hydrochloride has been explored for its ability to disrupt key signaling pathways in cancer cells. Preliminary studies indicate that this compound may exert its effects by modulating the activity of tyrosine kinases and other enzymes crucial for tumor growth and survival. These findings align with the broader trend of utilizing heterocyclic compounds as pharmacological tools to combat cancer.

Moreover, the compound's potential role in managing inflammatory diseases has not been overlooked. Chronic inflammation is a hallmark of many pathological conditions, including autoimmune disorders and cardiovascular diseases. The ability of 2,6-dimethoxy-3,5-pyridinediamine Hydrochloride to interact with inflammatory mediators has been investigated in preclinical models. By targeting specific inflammatory pathways, this molecule may offer a therapeutic edge in reducing inflammation and associated symptoms.

The synthesis of 2,6-dimethoxy-3,5-pyridinediamine Hydrochloride involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies have been employed to optimize the production process, making it more scalable for industrial applications. Techniques such as catalytic hydrogenation and nucleophilic substitution play a crucial role in constructing the desired pyridine framework.

The pharmacokinetic properties of 2,6-dimethoxy-3,5-pyridinediamine Hydrochloride are another critical aspect that influences its suitability as a drug candidate. Studies have begun to elucidate how this compound is metabolized and excreted within the body. Understanding these processes is essential for determining appropriate dosing regimens and minimizing potential side effects. Advanced analytical techniques like mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy have been instrumental in characterizing its metabolic profile.

In conclusion,2,6-Dimethoxy-3,5-pyridinediamine Hydrochloride (CAS No. 169381-75-3) represents a fascinating example of how structural modifications can enhance biological activity. Its unique chemical properties make it a valuable tool for researchers exploring new therapeutic strategies across multiple disease areas. As further studies continue to uncover its potential benefits,this compound is poised to play an increasingly significant role in the future of chemical biology and drug development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)